Metabolism of chemical carcinogens

Carcinogenesis

Volumn 21, Issue 3, 2000, Pages 345-351

  Guengerich, F Peter ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKANE DERIVATIVE; CARCINOGEN; DNA; ENZYME; HALIDE; HYDROCARBON; POLYCYCLIC HYDROCARBON;

BIOTRANSFORMATION; CARCINOGEN DNA INTERACTION; CARCINOGENESIS; DETOXIFICATION; DNA ADDUCT; DNA MODIFICATION; METABOLISM; PRIORITY JOURNAL; REVIEW;

EID: 0034097234     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/21.3.345     Document Type: Review

References (128)

1. Kadlubar, F.F. and Hammons, G.J. (1987) The role of cytochrome P-450 in the metabolism of chemical carcinogens. In Guengerich, F.P. (ed.) Mammalian Cytochromes P-450. CRC Press, Boca Raton, FL, Vol. 2, pp. 81-130.
2. Guengerich, F.P. (1988) Roles of cytochrome P-450 enzymes in chemical carcinogenesis and cancer chemotherapy. Cancer Res., 48, 2946-2954.
3. Jakoby, W.B. (1980) Enzymatic Basis of Detoxification. Academic Press, New York, Vols 1 and 2.
4. Miller, J.A. (1970) Carcinogenesis by chemicals: an overview. G.H.A. Clowes Memorial Lecture. Cancer Res., 30, 559-576.
5. Ames, B.N., Durston, W.E., Yamasaki, E. and Lee, F.D. (1973) Carcinogens are mutagens: A simple test system combining liver homogenates for activation and bacteria for detection. Proc. Natl Acad. Sci. USA, 70, 2281-2285.
6. Bresnick, E. (1979) Nuclear activation of polycyclic hydrocarbons. Drug Metab. Rev., 10, 209-223.
7. Shen, A.L., Fahl, W.E. and Jefcoate, C.R. (1980) Metabolism of benzo(a)pyrene by isolated hepatocytes and factors affecting covalent binding of benzo(a)pyrene metabolites to DNA in hepatocyte and microsomal systems. Arch. Biochem. Biophys., 204, 511-523.
8. Umbenhauer, D.R. and Pegg, A.E. (1981) Alkylation of intracellular and extracellular DNA by dimethylnitrosamine following activation by isolated rat hepatocytes. Cancer Res., 41, 3471-3474.
9. Miller, R.E. and Guengerich, F.P. (1983) Metabolism of trichloroethylene in isolated hepatocytes, microsomes, and reconstituted enzyme systems containing cytochrome P-450. Cancer Res., 43, 1145-1152.
10. Kapitulnik, J., Wislocki, P.G., Levin, W., Yagi, H., Jerina, D.M. and Conney, A.H. (1978) Tumorigenicity studies with diol-epoxides of benzo[a]pyrene which indicate that (±)-trans-7β,8α-dihydroxy-9α,10α-epoxy-7,8,9,10- tetrahydrobenzo[a]pyrene is an ultimate carcinogen in newborn mice. Cancer Res., 38, 354-358.
11. Rannug, U., Sundvall, A. and Ramel, C. (1978) The mutagenic effect of 1,2-dichloroethane on Salmonella typhimurium. I. Activation through conjugation with glutathione in vitro. Chem. Biol. Interact., 20, 1-16.
12. 7-guanyl)ethyl]glutathione adduct in glutathione-mediated binding of 1,2-dibromoethane to DNA. Proc. Natl Acad. Sci. USA, 80, 5266-5270.
13. Monks, T.J., Anders, M.W., Dekant, W., Stevens, J.L., Lau, S.S. and van Bladeren, P.J. (1990) Glutathione conjugate mediated toxicities. Toxicol. Appl. Pharmacol., 106, 1-19.
14. Anders, M.W. and Dekant, W. (1998) Glutathione-dependent bioactivation of haloalkanes. Annu. Rev. Pharmacol. Toxicol., 38, 501-537.
15. Grant, D.M., Josephy, P.D., Lord, H.L. and Morrison, L.D. (1992) Salmonella typhimurium strains expressing human arylamine N-acetyltransferases: metabolism and mutagenic activation of aromatic amines. Cancer Res., 52, 3961-3964.
16. Kaderlik, K.R., Mulder, G.J., Turesky, R.J., Lang, N.P., Teitel, C.H., Chiarelli, M.P. and Kadlubar, F.F. (1994) Glucuronidation of N-hydroxy heterocyclic amines by human and rat liver microsomes. Carcinogenesis, 15, 1695-1701.
17. Boberg, E.W., Miller, E.C., Miller, J.A., Poland, A. and Liem, A. (1983) Strong evidence from studies with brachymorphic mice and pentachlorophenol that 1′-sulfoöxysafrole is the major ultimate electrophilic and carcinogenic metabolite of 1′-hydroxysafrole in mouse liver. Cancer Res., 43, 5163-5173.
18. Lin, D.-X., Lang, N.P. and Kadlubar, F.F. (1995) Species differences in the biotransformation of the food-borne carcinogen 2-amino-1-methyl-6-phenylimazo[4,5-b]pyridine by hepatic microsomes and cytosols from humans, rats, and mice. Drug Metab. Dispos., 23, 518-524.
19. Kaderlik, K.R. and Kadlubar, F.F. (1995) Metabolic polymorphisms and carcinogen-DNA adduct formation in human populations. Pharmacogenetics, 5, S108-S117.
20. Poirier, M., Santella, R.M. and Weston, A. (2000) Carcinogen macromolecular adducts and their measurement. Carcinogenesis, 21, 353-359.
21. Marnett, L.J., Hurd, H.K., Hollstein, M.C., Levin, D.E., Esterbauer, H. and Ames, B.N. (1985) Naturally occurring carbonyl compounds are mutagens in Salmonella tester strain TA104. Mutat. Res., 148, 25-34.
22. Chung, F.L., Chen, H.J.C. and Nath, R.G. (1996) Lipid peroxidation as a potential endogenous source for the formation of exocyclic DNA adducts. Carcinogenesis, 17, 2105-2111.
23. Bolton, J.L., Pisha, E., Zhang, F. and Qiu, S. (1998) Role of quinoids in estrogen carcinogenesis. Chem. Res. Toxicol., 11, 1113-1127.
24. Cavalieri, E.L., Stack, D.E., Devanesan, P.D., Todorovic, R., Dwivedy, I., Higginbotham, S., Johansson, S.L., Patil, K., Gross, M.L., Gooden, J.K., Ramanathan, R., Cerny, R.L. and Rogan, E.G. (1997) Molecular origin of cancer: catechol estrogen-3,4-quinones as endogenous tumor initiators. Proc. Natl Acad. Sci. USA, 94, 10937-10942.
25. 2u-globulin nephropathy. Annu. Rev. Pharmacol. Toxicol., 30, 349-367.
26. Searle, C.E. (1984) Chemical Carcinogens. American Chemistry Society, Washington, DC.
27. Rosenkranz, H.S. and Mermelstein, R. (1985) The genotoxicity, metabolism and carcinogenicity of nitrated polycyclic aromatic hydrocarbons. J. Environ. Sci. Health, C3, 221-272.
28. El-Bayoumy, K. (1992) Environmental carcinogens that may be involved in human breast cancer etiology. Chem. Res. Toxicol., 5, 585-590.
29. Yamazaki, H., Mimura, M., Oda, Y., Inui, Y., Shiraga, T., Iwasaki, K., Guengerich, F.P. and Shimada, T. (1993) Roles of different forms of cytochrome P450 in the activation of the promutagen 6-aminochrysene to genotoxic metabolites in human liver microsomes. Carcinogenesis, 14, 1271-1278.
30. Chae, Y.H., Yun, C.H., Guengerich, F.P., Kadlubar, F.F. and El-Bayoumy, K. (1993) Roles of human hepatic and pulmonary cytochrome P450 enzymes in the metabolism of the environmental carcinogen 6-nitrochrysene. Cancer Res., 53, 2028-2034.
31. Moreno, S.N.J., Schreiber, J. and Mason, R.P. (1986) Nitrobenzyl radical metabolites from microsomal reduction of nitrobenzyl chlorides. J. Biol. Chem., 261, 7811-7815.
32. Shimada, T. and Guengerich, F.P. (1990) Inactivation of 1,3-, 1,6-, and 1,8-dinitropyrene by human and rat microsomes. Cancer Res., 50, 2036-2043.
33. Djuric, Z., Potter, D.W., Heflich, R.H. and Beland, F.A. (1986) Aerobic and anaerobic reduction of nitrated pyrenes in vitro. Chem. Biol. Interact., 59, 309-324.
34. Wörner, W. and Oesch, F. (1984) Identity of dihydrodiol dehydrogenase and 3 alpha-hydroxysteroid dehydrogenase in rat but not in rabbit liver cytosol. FEBS Lett., 170, 263-267.
35. Flowers-Geary, L., Bleczinski, W., Harvey, R.G. and Penning, T.M. (1996) Cytotoxicity and mutagenicity of polycyclic aromatic hydrocarbon o-quinones produced by dihydrodiol dehydrogenase. Chem. Biol. Interact., 99, 55-72.
36. Smithgall, T.E., Harvey, R.G. and Penning, T.M. (1988) Oxidation of the trans-3,4-dihydrodiol metabolites of the potent carcinogen 7,12-dimethylbenz(a)anthracene and other benz(a)anthracene derivatives by 3a-hydroxysteroid-dihydrodiol dehydrogenase: effects of methyl substitution on velocity and stereochemical course of trans-dihydrodiol oxidation. Cancer Res., 48, 1227-1232.
37. Miller, R.E. and Guengerich, F.P. (1982) Oxidation of trichloroethylene by liver microsomal cytochrome P-450: evidence for chlorine migration in a transition state not involving trichloroethylene oxide. Biochemistry, 21, 1090-1097.
38. Liebler, D.C. and Guengerich, F.P. (1983) Olefin oxidation by cytochrome P-450: evidence for group migration in catalytic intermediates formed with vinylidene chloride and trans-1-phenyl-1-butene. Biochemistry, 22, 5482-5489.
39. Mansuy, D., Leclaire, J., Fontecave, M. and Momenteau, M. (1984) Oxidation of monosubstituted olefins by cytochrome P-450 and heme models: evidence for the formation of aldehydes in addition to epoxides and allylic alcohols. Biochem. Biophys. Res. Commun., 119, 319-325.
40. Ortiz de Montellano, P.R. (1986) Oxygen activation and transfer. In Ortiz de Montellano, P.R. (ed.) Cytochrome P-450. Plenum Press, New York, pp. 217-271.
41. Liebler, D.C., Meredith, M.J. and Guengerich, F.P. (1985) Formation of glutathione conjugates by reactive metabolites of vinylidene chloride in microsomes and isolated hepatocytes. Cancer Res., 45, 186-193.
42. 7-guanyl)ethyl]glutathione in DNA. J. Am. Chem. Soc., 110, 3284-3291.
43. 7-guanyl)ethyl]glutathione as a mutagenic lesion formed from ethylene dibromide. J. Biol. Chem., 267, 6672-6679.
44. Thier, R., Pemble, S.E., Taylor, J.B., Humphreys, W.G., Persmark, M., Ketterer, B. and Guengerich, F.P. (1993) Expression of mammalian glutathione S-transferase 5-5 in Salmonella typhimurium TA 1535 leads to base-pair mutations upon exposure to dihalomethanes. Proc. Natl Acad. Sci. USA, 90, 8576-8580.
45. Pegram, R.A., Andersen, M.E., Warren, S.H., Ross, T.M. and Claxton, L.D. (1997) Glutathione S-transferase-mediated mutagenicity of trihalomethanes in Salmonella typhimurium: contrasting results with bromodichloromethane and chloroform. Toxicol. Appl. Pharmacol., 144, 183-188.
46. Marsch, G.A., Jankowiak, R., Small, G.J., Hughes, N.C. and Phillips, D.H. (1992) Evidence of involvment of multiple sites of metabolism in the in vivo covalent binding of dibenzo[a,h]pyrene to DNA. Chem. Res. Toxicol., 5, 765-772.
47. 32P-labeling test for DNA damage. Proc. Natl Acad. Sci. USA, 78, 6126-6129.
48. Fujii-Kuriyama, Y., Mizukami, Y., Kawajiri, K., Sogawa, K. and Muramatsu, M. (1982) Primary structure of a cytochrome P-450: coding nucleotide sequence of phenobarbital-inducible cytochrome P-450 cDNA from rat liver. Proc. Natl Acad. Sci. USA, 79, 2793-2797.
49. Conney, A.H., Miller, E.C. and Miller, J.A. (1956) The metabolism of methylated aminoazo dyes. V. Evidence for induction of enzyme synthesis in the rat by 3-methylcholanthrene. Cancer Res., 16, 450-459.
50. Nebert, D.W. and Jensen, N.M. (1979) The Ah locus: genetic regulation of the metabolism of carcinogens, drugs, and other environmental chemicals by cytochrome P-450-mediated monooxygenases. Crit. Rev. Biochem., 6, 401-438.
51. Kellerman, G., Shaw, C.R. and Luyten-Kellerman, M. (1973) Aryl hydrocarbon hydroxylase inducibility and bronchogenic carcinoma. N. Engl. J. Med., 298, 934-937.
52. Habig, W.H., Pabst, M.J. and Jakoby, W.B. (1974) Glutathione S-transferases: the first enzymatic step in mercapturic acid formation. J. Biol. Chem., 249, 7130-7139.
53. Haugen, D.A., van der Hoeven, T.A. and Coon, M.J. (1975) Purified liver microsomal cytochrome P-450: separation and characterization of multiple forms. J. Biol. Chem., 250, 3567-3570.
54. Tukey, R.H. and Tephly, T.R. (1981) Purification and properties of rabbit liver estrone and p-nitrophenol UDP-glucuronyltransferases. Arch. Biochem. Biophys., 209, 565-578.
55. Ryan, D., Lu, A.Y.H. and Levin, W. (1978) Purification of cytochrome P-450 and P-448 from rat liver microsomes. Methods Enzymol., 52, 117-123.
56. Guengerich, F.P. (1978) Separation and purification of multiple forms of microsomal cytochrome P-450. Partial characterization of three apparently homogeneous cytochromes P-450 prepared from livers of phenobarbitaland 3-methylcholanthrene-treated rats. J. Biol. Chem., 253, 7931-7939.
57. Guengerich, F.P. (1995) Human cytochrome P450 enzymes. In Ortiz de Montellano, P.R. (ed.) Cytochrome P450. Plenum Press, New York, pp. 473-535.
58. Lee, S.S.T., Buters, J.T.M., Pineau, T., Fernandez-Salguero, P. and Gonzalez, F.J. (1996) Role of CYP2E1 in the hepatotoxicity of acetaminophen. J. Biol. Chem., 271, 12063-12067.
59. Fernandez-Salguero, P.M., Hilbert, D.M., Rudikoff, S., Ward, J.M. and Gonzalez, F.J. (1996) Aryl-hydrocarbon receptor-deficient mice are resistant to 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced toxicity. Toxicol. Appl. Pharmacol., 140, 173-179.
60. Guengerich, F.P. (1998) The environmental genome project: functional analysis of polymorphisms. Environ. Health Perspect., 106, 365-368.
61. Sporn, M.B. and Suh, N. (2000) Chemoprevention of cancer. Carcinogenesis, 21, 525-530.
62. Benson, A.M., Batzinger, R.P., Ou, S.Y.L., Bueding, E., Cha, Y.N. and Talalay, P. (1978) Elevation of hepatic glutathione S-transferase activities and protection against mutagenic metabolites of benzo(a)pyrene by dietary antioxidants. Cancer Res., 38, 4486-4495.
63. Davidson, N.E., Egner, P.A. and Kensler, T.W. (1990) Transcriptional control of glutathione S-transferase gene expression by the chemoprotective agent 5-(2-pyrazinyl)-4-methyl-1,2-dithiole-3-thione (oltipraz) in rat liver. Cancer Res., 50, 2251-2255.
64. 1 metabolism in human hepatocytes in primary culture. Cancer Res., 55, 5574-5579.
65. Jiao, D., Smith, T.J., Kim, S., Yang, C.S., Desai, D., Amin, S. and Chung, F.L. (1996) The essential role of the functional group in alkyl isothiocyanates for inhibition of tobacco nitrosamine-induced lung tumorigenesis. Carcinogenesis, 17, 755-759.
66. Ahn, D., Putt, D., Kresty, L., Stoner, G.D., Fromm, D. and Hollenberg, P.F. (1996) The effects of dietary ellagic acid on rat hepatic and esophageal mucosal cytochromes P450 and phase II enzymes. Carcinogenesis, 17, 821-828.
67. 7-guanyl)ethyl]glutathione from ethylene dibromide: effects of modulation of glutathione and glutathione S-transferase levels and the lack of a role for sulfation. Carcinogenesis, 11, 419-424.
68. Sherratt, P.J., Manson, M.M., Thomson, A.M., Hissink, E.A.M., Neal, G.E., Vanbladeren, P.J., Green, T. and Hayes, J.D. (1998) Increased bioactivation of dihaloalkanes in rat liver due to induction of class theta glutathione S-transferase T1-1. Biochem. J., 335, 619-630.
69. McManus, M.E., Burgess, W.M., Veronese, M.E., Huggett, A., Quattrochi, L.C. and Tukey, R.H. (1990) Metabolism of 2-acetylaminofluorene and benzo(a)pyrene and activation of food-derived heterocyclic amine mutagens by human cytochromes P-450. Cancer Res., 50, 3367-3376.
70. Shimada, T., Iwasaki, M., Martin, M.V. and Guengerich, F.P. (1989) Human liver microsomal cytochrome P-450 enzymes involved in the bioactivation of procarcinogens detected by umu gene response in Salmonella typhimurium TA 1535/pSK1002. Cancer Res., 49, 3218-3228.
71. Gonzalez, F.J. (1993) Molecular biology of human xenobiotic-metabolizing cytochromes P450: role of vaccinia virus cDNA expression in evaluating catalytic function. Toxicology, 82, 77-88.
72. Guengerich, F.P., Gillam, E.M.J. and Shimada, T. (1996) New applications of bacterial systems to problems in toxicology. Crit. Rev. Toxicol., 26, 551-583.
73. Suzuki, A., Kushida, H., Iwata, H., Watanabe, M., Nohmi, T., Fujita, K., Gonzalez, F.J. and Kamataki, T. (1998) Establishment of a Salmonella tester strain highly sensitive to mutagenic heterocyclic amines. Cancer Res., 58, 1833-1838.
74. Josephy, P.D., Evans, D.H., Parikh, A. and Guengerich, F.P. (1998) Expression of active human cytochrome P450 1A2, NADPH-cytochrome P450 reductase, and N-acetyltransferase in Escherichia coli: metabolic activation of aromatic amine mutagens. Chem. Res. Toxicol., 11, 70-74.
75. Kranendonk, M., Mesquita, P., Laires, A., Vermeulen, N.P.E. and Rueff, J. (1998) Expression of human cytochrome P450 1A2 in Escherichia coli: a system for biotransformation and genotoxicity studies of chemical carcinogens. Mutagenesis, 13, 263-269.
76. Andersen, M.E., Krewski, D. and Withey, J.R. (1993) Physiological pharmacokinetics and cancer risk assessment. Cancer Lett., 69, 1-14.
77. Bois, F., Krowech, G. and Zeise, L. (1995) Modeling human interindividual variability in metabolism and risk: the example of 4-aminobiphenyl. Risk Anal., 15, 205-213.
78. Reitz, R.H., Mendrala, A. and Guengerich, F.P. (1989) In vitro metabolism of methylene chloride in human and animal tissues: use in physiologically-based pharmacokinetic models. Toxicol. Appl. Pharmacol., 97, 230-246.
79. Miller, E.C. and Miller, J.A. (1947) The presence and significance of bound amino azodyes in the livers of rats fed p-dimethylaminoazobenzene. Cancer Res., 7, 468-480.
80. Dekant, W., Koob, M. and Henschler, D. (1990) Metabolism of trichloroethene - in vivo and in vitro evidence for activation by glutathione conjugation. Chem. Biol. Interact., 73, 89-101.
81. Goeptar, A.R., Commandeur, J.N.M., van Ommen, B., van Bladeren, P.J. and Vermeulen, N.P.E. (1995) Metabolism and kinetics of trichloroethylene in relation to toxicity and carcinogenicity. Relevance to the mercapturic acid pathway. Chem. Res. Toxicol., 8, 3-21.
82. Cavalieri, E.L. and Rogan, E.G. (1990) Radical cations in aromatic hydrocarbon carcinogenesis. Free Rad. Res. Commun., 11, 77-87.
83. Melendez-Colon, V.J., Smith, C.A., Seidel, A., Luch, A., Platt, K.L. and Baird, W.M. (1997) Formation of stable adducts and absence of depurinating DNA adducts in cells and DNA treated with the potent carcinogen dibenzo[a,l]pyrene or its diol epoxides. Proc. Natl Acad. Sci. USA, 94, 13542-13547.
84. Zhang, J.T., Dai, W. and Harvey, R.G. (1998) Synthesis of higher oxidized metabolites of dibenz[a,j]anthracene implicated in the mechanism of carcinogenesis. J. Org. Chem., 63, 8125-8132.
85. Yamazoe, Y., Zenser, T.V., Miller, D.W. and Kadlubar, F.F. (1988) Mechanism of formation and structural characterization of DNA adducts derived from peroxidative activation of benzidine. Carcinogenesis, 9, 1635-1641.
86. Guengerich, F.P. (1997) Biotransformation, Vol. 3 of Comprehensive Toxicology. Pergamon, Oxford, UK.
87. Ji, X.H., Johnson, W.W., Sesay, M.A., Dickert, L., Prasad, S.M., Ammon, H.L., Armstrong, R.N. and Gilliland, G.L. (1994) Structure and function of the xenobiotic substrate binding site of a glutathione S-transferase as revealed by X-ray crystallographic analysis of product complexes with the diastereomers of 9-(S-glutathionyl)-10-hydroxy-9,10-dihydrophenanthrene. Biochemistry, 33, 1043-1052.
88. Kakuta, Y., Petrotchenko, E.V., Pedersen, L.C. and Negishi, M. (1998) The sulfuryl transfer mechanism. Crystal structure of a vanadate complex of estrogen sulfotransferase and mutational analysis. J. Biol. Chem., 273, 27325-27330.
89. Anzenbacher, P., Niwa, T., Tolbert, L.M., Sirimanne, S.S. and Guengerich, F.P. (1996) Oxidation of 9-alkyl anthracenes by cytochrome P450 2B1, horseradish peroxidase, and iron tetraphenylporphin/ iodosylbenzene systems. Anaerobic and aerobic mechanisms. Biochemistry, 35, 2512-2520.
90. Tzeng, H.-F., Laughlin, L.T., Lin, S. and Armstrong, R.N. (1996) The catalytic mechanism of microsomal epoxide hydrolase involves reversible formation and rate-limiting hydrolysis of the alkyl-enzyme intermediate. J. Am. Chem. Soc., 118, 9436-9437.
91. 5 on steady-state kinetics. J. Biol. Chem., 272, 29643-29651.
92. m and V/K in enzyme kinetics. J. Chem. Ed., 75, 1153-1157.
93. Andersen, M.E., Clewell, H.J. and Frederick, C.B. (1995) Applying simulation modeling to problems in toxicology and risk assessment - a short perspective. Toxicol. Appl. Pharmacol., 133, 181-187.
94. Nelson, D.R., Koymans, L., Kamataki, T., Stegeman, J.J., Feyereisen, R., Waxman, D.J., Waterman, M.R., Gotoh, O., Coon, M.J., Estabrook, R.W., Gunsalus, I.C. and Nebert, D.W. (1996) P450 superfamily: update on new sequences, gene mapping, accession numbers, and nomenclature. Pharmacogenetics, 6, 1-42.
95. Board, P., Coggan, M., Johnston, P., Ross, V., Suzuki, T. and Webb, G. (1991) Genetic heterogeneity of the human glutathione transferases: a complex of gene families. Pharmacol. Ther., 48, 357-369.
96. Ayesh, R., Idle, J.R., Ritchie, J.C., Crothers, M.J. and Hetzel, M.R. (1984) Metabolic oxidation phenotypes as markers for susceptibility to lung cancer. Nature, 312, 169-170.
97. Shaw, G.L., Falk, R.T., Frame, J.N., Weiffenbach, B., Nesbitt, J.V., Pass, H.I., Caporaso, N.E., Moir, D.T. and Tucker, M.A. (1998) Genetic polymorphism of CYP2D6 and lung cancer risk. Cancer Epidem. Biomarker. Prev., 7, 215-219.
98. Liu, S. and Pickett, C.B. (1996) The rat liver glutathione S-transferase Ya subunit gene: characterization of the binding properties of a nuclear protein from HepG2 cells that has high affinity for the antioxidant response element. Biochemistry, 35, 11517-11521.
99. Pinkus, R., Weiner, L.M. and Daniel, V. (1996) Role of oxidants and antioxidants in the induction of AP-1, NF-κB, and glutathione S-transferase gene expression. J. Biol. Chem., 271, 13422-13429.
100. Wasserman, W.W. and Fahl, W.E. (1997) Functional antioxidant responsive elements. Proc. Natl Acad. Sci. USA, 94, 5361-5366.
101. Lehmann, J.M., McKee, D.D., Watson, M.A., Wilson, T.M., Moore, J.T. and Kliewer, S.A. (1998) The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions. J. Clin. Invest., 102, 1016-1023.
102. Honkakoski, P. and Negishi, M. (1997) Characterization of a phenobarbital-responsive enhancer module in mouse P450 Cyp2b10 gene. J. Biol. Chem., 272, 14943-14949.
103. Ma, Q. and Whitlock, J.P.Jr (1997) A novel cytoplasmic protein that interacts with the Ah receptor, contains tetratricopeptide repeat motifs, and augments the transcriptional response to 2,3,7,8-tetrachlorodibenzo-p-dioxin. J. Biol. Chem., 272, 8878-8884.
104. Probst, M.R., Fan, C.M., Tessier-Lavigne, M. and Hankinson, O. (1997) Two murine homologs of the Drosphilia single-minded protein that interact with the mouse aryl hydrocarbon receptor nuclear translocator protein. J. Biol. Chem., 272, 4451-4457.
105. Carver, L.A. and Bradfield, C.A. (1997) Ligand-dependent interaction of the aryl hydrocarbon receptor with a novel immunophilin homolog in vivo. J. Biol. Chem., 272, 11452-11456.
106. Carver, L.A., LaPres, J.J., Jain, S., Dunham, E.E. and Bradfield, C.A. (1998) Characterization of the Ah receptor-associated protein, ARA9. J. Biol. Chem., 273, 33580-33587.
107. Sogawa, K. and Fujii-Kuriyama, Y. (1997) Ah receptor, a novel ligand-activated transcription factor. J. Biochem., 122, 1975-1979.
108. Hahn, M.E. (1998) Mechanisms of innate and acquired resistance to dioxin-like compounds. Rev. Toxicol., 2, 395-443.
109. Bradfield, C.A., Gallo, M.A., Gasiewicz, T.A., Greenberg, R.S., Greenlee, W.F., Margolick, J., Mattison, D.R., Munson, P., Neal, R.A., Okey, A.B., Olive, D.L., Poland, A., Rifkind, A.B., Rodricks, J.V., Rozman, K., Safe, S.H., Starr, T.B. and Sutter, T.R. (1994) EPA dioxin reassessment. Science, 266, 1628-1629.
110. Richardson, H.L., Stier, A.R. and Borsos-Nachtnebel, E. (1952) Liver tumor inhibition and adrenal histologic responses in rats to which 3′-methyl-4-dimethylaminoazobenzene and 20-methylcholanthrene were simultaneously administered. Cancer Res., 12, 356-361.
111. Nebert, D.W. (1989) The Ah locus: genetic differences in toxicity, cancer, mutation, and birth defects. Crit. Rev. Toxicol., 20, 153-174.
112. McClain, R.M. (1994) Mechanistic considerations in the regulation and classification of chemical carcinogens. In Kotsonis, F.N., Mackey, M. and Hjelle, J. (eds) Nutritional Toxicology. Raven Press Ltd, New York, pp. 273-304.
113. Veber, D.F., Drake, F.H. and Gowen, M. (1997) The new partnership of genomics and chemistry for accelerated drug development. Curr. Opin. Chem. Biol., 1, 151-156.
114. DeRisi, J.L., Iyer, V.R. and Brown, P.O. (1997) Exploring the metabolic and genetic control of gene expression on a genomic scale. Science, 278, 680-686.
115. 1 exo-8,9-epoxide and relevance to toxicity and detoxification. Drug Metab. Rev., 31, 141-158.
116. Shimada, T. and Guengerich, F.P. (1991) Activation of amino-α-carboline, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine, and a copper phthalocyanine cellulose extract of cigarette smoke condensate by cytochrome P-450 enzymes in rat and human liver microsomes. Cancer Res., 51, 5284-5291.
117. Boberg, E.W., Liem, A., Miller, E.C. and Miller, J.A. (1987) Inhibition by pentachlorophenol of the initiating and promoting activites of 1′-hydroxysafrole for the formation of enzyme-altered foci and tumors in rat liver. Carcinogenesis, 8, 531-539.
118. Drakoulis, N., Minks, T., Ploch, M., Otte, F., Heinemeyer, G., Kampf, D., Loddenkemper, R. and Roots, I. (1986) Questionable association of debrisoquine hydroxilator phenotype and risk for bronchial carcinoma. Acta Pharmacol. Toxicol., 59 (Suppl. 5), 220.
119. Alexandrie, A.K., Sundberg, M.I., Seidegärd, J., Tornling, G. and Rannug, A. (1994) Genetic susceptibility to lung cancer with special emphasis on CYP1A1 and GSTM1: a study on host factors in relation to age at onset, gender and histological cancer types. Carcinogenesis, 15, 1785-1790.
120. Brockmöller, J., Kerb, R., Drakoulis, N., Nitz, M. and Roots, I. (1993) Genotype and phenotype of glutathione S-transferase class A isoenzymes A and ψ in lung cancer patients and controls. Cancer Res., 53, 1004-1011.
121. Kawajiri, K., Nakachi, K., Imai, K., Watanabe, J. and Hayashi, S.-I. (1993) The cytochrome P4501A1 gene and cancer susceptibility. Crit. Rev. Oncol. Hematol., 14, 77-87.
122. Bailey, L.R., Roodi, N., Dupont, W.D. and Parl, F.F. (1998) Association of cytochrome P450 1B1 (CYP1B1) polymorphism with steroid receptor status in breast cancer. Cancer Res., 58, 5038-5041.
123. 462: assessment of a role for the rare allele in carcinogenesis. Cancer Res., 56, 3926-3933.
124. Persson, I., Johansson, I. and Ingelman-Sundberg, M. (1997) In vitro kinetics of two human CYP1A1 variant enzymes suggested to be associated with interindividual differences in cancer susceptibility. Biochem. Biophys. Res. Commun., 231, 227-230.
125. Hanna, I.H., Roodi, N., Guengerich, F.P. and Parl, F.F. (1999) Pharmacogenetics of human cytochrome P450 1B1. Proc. Am. Assoc. Cancer Res., 40, 50-51.
126. Philip, P.A., Fitzgerald, D.L., Cartwright, R.A., Peake, M.D. and Rogers, H.J. (1988) Polymorphic N-acetylation capacity in lung cancer. Carcinogenesis, 9, 491-493.
127. d'Errico, A., Taioli, E., Chen, X. and Vineis, P. (1996) Genetic metabolic polymorphisms and the risk of cancer: a review of the literature. Biomarkers, 1, 149-173.
128. Perera, F.P. and Weinstein, I.B. (2000) Molecular epidemiology: recent advances and future directions. Carcinogenesis, 21, 517-524.